Synaptogenix, Inc.股价重挫12.58% 市值跌6.68万美元

市场透视2024-12-04

北京时间2024年12月04日22时30分，Synaptogenix, Inc.（SNPX.us）股票出现异动，股价快速下跌12.58%。截至发稿，该股报2.64美元/股，成交量43股，换手率0.00%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-5.74百万美元，每股收益-4.58美元，毛利-1689.00美元，市盈率3.38倍。机构评级方面，在所有1家参与评级的...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2488942171?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-04 22:30","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2488942171","market":"us","top_or_hot":-1,"title":"Synaptogenix, Inc.股价重挫12.58% 市值跌6.68万美元","media":"市场透视","content":"<div>\n<p>北京时间2024年12月04日22时30分，Synaptogenix, Inc.（SNPX.us）股票出现异动，股价快速下跌12.58%。截至发稿，该股报2.64美元/股，成交量43股，换手率0.00%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-5.74百万美元，每股收益-4.58美元，毛利-1689.00美元，市盈率3.38倍。机构评级方面，在所有1家参与评级的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204223049971ba020&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Synaptogenix, Inc.股价重挫12.58% 市值跌6.68万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSynaptogenix, Inc.股价重挫12.58% 市值跌6.68万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-04 22:30 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204223049971ba020&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年12月04日22时30分，Synaptogenix, Inc.（SNPX.us）股票出现异动，股价快速下跌12.58%。截至发稿，该股报2.64美元/股，成交量43股，换手率0.00%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-5.74百万美元，每股收益-4.58美元，毛利-1689.00美元，市盈率3.38倍。机构评级方面，在所有1家参与评级的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204223049971ba020&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SNPX","symbol_name":"2倍做多SNPS ETF-Tradr","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204223049971ba020&s=b","article_id":"2488942171","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204223049971ba020&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2488942171","pubTimestamp":1733322649,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年12月04日22时30分，Synaptogenix, Inc.股票出现异动，股价快速下跌12.58%。Synaptogenix, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Cyclerion Therapeutics, Inc.、Heron Therapeutics, Inc.、Eterna Therapeutics Inc.涨幅较大，Cyclerion Therapeutics, Inc.、Can Fite Biopharma Ltd、Windtree Therapeutics, Inc.较为活跃，换手率分别为1166.71%、189.27%、109.36%，振幅较大的相关个股有Theratechnologies Inc.、Organovo Holdings, Inc.、Serina Therapeutics, Inc.，振幅分别为6.79%、5.30%、3.70%。Synaptogenix, Inc.公司简介：Synaptogenix Inc 是一家生物制药公司，在临床前和临床开发中具有产品候选者。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"SNPX":"2倍做多SNPS ETF-Tradr","BK4139":"生物科技"},"translate_title":"Synaptogenix, Inc. 's stock plunges 12.58% and its market value falls by $66,800","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SNPX":0.9},"content_text":"北京时间2024年12月04日22时30分，Synaptogenix, Inc.（SNPX.us）股票出现异动，股价快速下跌12.58%。截至发稿，该股报2.64美元/股，成交量43股，换手率0.00%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-5.74百万美元，每股收益-4.58美元，毛利-1689.00美元，市盈率3.38倍。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Synaptogenix, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Cyclerion Therapeutics, Inc.、Heron Therapeutics, Inc.、Eterna Therapeutics Inc.涨幅较大，Cyclerion Therapeutics, Inc.、Can Fite Biopharma Ltd、Windtree Therapeutics, Inc.较为活跃，换手率分别为1166.71%、189.27%、109.36%，振幅较大的相关个股有Theratechnologies Inc.、Organovo Holdings, Inc.、Serina Therapeutics, Inc.，振幅分别为6.79%、5.30%、3.70%。Synaptogenix, Inc.公司简介：Synaptogenix Inc 是一家生物制药公司，在临床前和临床开发中具有产品候选者。它主要侧重于开发一个基于一种名为布约他汀的药物候选药物的产品平台，用于治疗阿尔茨海默氏症，目前正处于临床测试阶段。它还在评估布赖他汀的其他神经退行性或认知性疾病和功能障碍，如脆弱X综合征，多发性硬化症和尼曼-皮克C型疾病，这些疾病已经经过临床前测试。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2488942171","isCrawlerRequest":true}